Hypoxia regulates Hippo signalling through the SIAH2 ubiquitin E3 ligase

被引:205
|
作者
Ma, Biao [1 ]
Chen, Yan [1 ]
Chen, Ling [1 ]
Cheng, Hongcheng [1 ]
Mu, Chenglong [1 ]
Li, Jie [1 ]
Gao, Ruize [1 ]
Zhou, Changqian [1 ]
Cao, Lei [1 ]
Liu, Jinhua [1 ]
Zhu, Yushan [1 ]
Chen, Quan [1 ,2 ]
Wu, Shian [1 ]
机构
[1] Nankai Univ, Coll Life Sci, Tianjin Key Lab Prot Sci, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China
[2] Chinese Acad Sci, Inst Zool, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100101, Peoples R China
关键词
TUMOR-SUPPRESSOR; PROMOTES APOPTOSIS; CELL-PROLIFERATION; GROWTH-CONTROL; BREAST-CANCER; SIZE-CONTROL; PATHWAY; DROSOPHILA; GENE; HOMOLOG;
D O I
10.1038/ncb3073
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The Hippo signalling pathway plays important roles in animal development, physiology and tumorigenesis(1-3). Understanding how the activity of this pathway is regulated by the cellular microenvironment remains a major challenge. Here we elucidate a molecular mechanism by which hypoxia deactivates Hippo signalling. We demonstrate that the E3 ubiquitin ligase SIAH2 stimulates YAP by destabilizing LATS2, a critical component of the Hippo pathway, in response to hypoxia. Loss of SIAH2 suppresses tumorigenesis in a LATS2-dependent manner in a xenograft mouse model. We further show that YAP complexes with HIF1 alpha and is essential for HIF1 alpha stability and function in tumours in vivo. LATS2 is downregulated in human breast tumours and negatively correlates with SIAH2 expression levels, indicating that the SIAH2-LATS2 pathway may have a role in human cancer. Our data uncover oxygen availability as a microenvironment signal for the Hippo pathway and have implications for understanding the regulation of Hippo signalling in tumorigenesis.
引用
收藏
页码:95 / +
页数:23
相关论文
共 50 条
  • [1] Hypoxia regulates Hippo signalling through the SIAH2 ubiquitin E3 ligase
    Biao Ma
    Yan Chen
    Ling Chen
    Hongcheng Cheng
    Chenglong Mu
    Jie Li
    Ruize Gao
    Changqian Zhou
    Lei Cao
    Jinhua Liu
    Yushan Zhu
    Quan Chen
    Shian Wu
    [J]. Nature Cell Biology, 2015, 17 : 95 - 103
  • [2] The Ubiquitin E3 Ligase Siah2 Regulates PPARγ Activity in Adipocytes
    Kilroy, Gail
    Mynatt, Randall L.
    Floyd, Z. Elizabeth
    [J]. DIABETES, 2011, 60 : A125 - A125
  • [3] The Ubiquitin Ligase Siah2 and the Hypoxia Response
    Nakayama, Koh
    Qi, Jianfei
    Ronai, Ze'ev
    [J]. MOLECULAR CANCER RESEARCH, 2009, 7 (04) : 443 - 451
  • [4] CHK2 stability is regulated by the E3 ubiquitin ligase SIAH2
    C García-Limones
    M Lara-Chica
    C Jiménez-Jiménez
    M Pérez
    P Moreno
    E Muñoz
    M A Calzado
    [J]. Oncogene, 2016, 35 : 4289 - 4301
  • [5] CHK2 stability is regulated by the E3 ubiquitin ligase SIAH2
    Garcia-Limones, C.
    Lara-Chica, M.
    Jimenez-Jimenez, C.
    Perez, M.
    Moreno, P.
    Munoz, E.
    Calzado, M. A.
    [J]. ONCOGENE, 2016, 35 (33) : 4289 - 4301
  • [6] Regulation of MYPT1 stability by the E3 ubiquitin ligase SIAH2
    Twomey, Erin
    Li, Yan
    Lei, Joy
    Sodja, Caroline
    Ribecco-Lutkiewicz, Maria
    Smith, Brandon
    Fang, Hung
    Bani-Yaghoub, Mahmud
    McKinnell, Iain
    Sikorska, Marianna
    [J]. EXPERIMENTAL CELL RESEARCH, 2010, 316 (01) : 68 - 77
  • [7] The E3 Ubiquitin Ligase SIAH2 Is a Prosurvival Factor Overexpressed in Oral Cancer
    Hsieh, Shu-Chen
    Kuo, Sheng-Nan
    Zheng, Yi-Han
    Tsai, Ming-Hsui
    Lin, Yu-Sheng
    Lin, Ju-Hwa
    [J]. ANTICANCER RESEARCH, 2013, 33 (11) : 4965 - 4973
  • [8] Investigating the Molecular Basis of Siah1 and Siah2 E3 Ubiquitin Ligase Substrate Specificity
    Gopalsamy, Anupriya
    Hagen, Thilo
    Swaminathan, Kunchithapadam
    [J]. PLOS ONE, 2014, 9 (09):
  • [9] The Ubiquitin Ligase Siah2 Regulates PPARγ Activity in Adipocytes
    Kilroy, Gail
    Kirk-Ballard, Heather
    Carter, Lauren E.
    Floyd, Z. Elizabeth
    [J]. ENDOCRINOLOGY, 2012, 153 (03) : 1206 - 1218
  • [10] Downregulation of SIAH2, an ubiquitin E3 ligase, is associated with resistance to endocrine therapy in breast cancer
    Maurice P. H. M. Jansen
    Kirsten Ruigrok-Ritstier
    Lambert C. J. Dorssers
    Iris L. van Staveren
    Maxime P. Look
    Marion E. Meijer-van Gelder
    Anieta M. Sieuwerts
    Jozien Helleman
    Stefan Sleijfer
    Jan G. M. Klijn
    John A. Foekens
    Els M. J. J. Berns
    [J]. Breast Cancer Research and Treatment, 2009, 116 : 263 - 271